Menu
Contact

About Valcare

Company
A woman and a man talking in an office setting at a desk.
Company

The Story behind Valcare

Valcare Medical, Inc. is dedicated to revolutionizing mitral regurgitation treatment by delivering transcatheter solutions that match the efficacy and durability of surgical annuloplasty while eliminating the risks of open-heart surgery.

The company’s flagship investigational AMEND™ Transcatheter Mitral Valve Repair Annuloplasty System is designed to restore normal mitral valve geometry and function via a percutaneous approach.

Valcare Medical is a privately held company headquartered in Wilmington, Delaware, USA.

Meet the Team

Portrait of Steve Sandweg

Steve Sandweg

Chief Executive Officer

Steve brings over 30 years of sales leadership and commercial experience in cardiovascular and structural heart technologies. His career includes progressively senior roles at Boston Scientific, Medtronic, Direct Flow Medical, Keystone Heart, and EBR Systems, where he most recently served as General Manager and Chief Commercial Officer, respectively.

Portrait of Nadav Yellin

Nadav Yellin

Chief Operating Officer

Nadav is a seasoned leader in cardiovascular device design with a unique track record of driving innovation from concept through clinical application. Since Valcare’s founding, he has led the company’s product development, overseeing a broad, multidisciplinary scope that spans engineering, operations, and clinical activities. His leadership integrates cross-functional teams to advance complex technologies from early development through clinical readiness.

Portrait of David Meerkin

Dr. David Meerkin

Chief Medical Officer

Dr. David Meerkin is an interventional cardiologist and a pioneer of interventions in structural and congenital heart disease. He has been involved in extensive device development for nearly two decades consulting for Israeli and international companies. A regular speaker at international medical conferences, Dr. Meerkin trained in Melbourne, Australia and specialized in Internal Medicine & Cardiology at the Shaare Zedek Medical Center in Jerusalem and in Interventional Cardiology at the Montreal Heart Institute in Canada.

Portrait of Madhuri Bhat

Madhuri Bhat

Chief Regulatory & Clinical Officer

Madhuri has over 25 years of experience in public affairs, public policy, due diligence, clinical, quality, and regulatory. She led several successful pivotal clinical trials and multiple registries and secured PMA, 510(K), and CE Mark regulatory approvals and clearances globally for Class II and III cardiovascular systems. Madhuri was the Chief Regulatory Officer at EBR Systems and has served as Vice-President RA/Clinical for companies in the reproductive, GI, neurological, urological, and cardiovascular such as Kyma Medical (Zoll).  Prior to that, she was the VP of RA/QC at Barrx Medical and VP of RA/Clinical at Corventis (Medtronic) and held leadership roles at Guidant and Abbott.

Portrait of Yoni Mizrahi

Yoni Mizrahi

Chief Financial Officer

Yoni is an experienced CFO with a strong track record in high-growth technology companies, leading financial operations from start-up to global expansion and successful exits. She served as CFO of LightCyber, acquired by Palo Alto Networks, where she built the company’s financial and operational infrastructure, and held senior finance roles at UroGen Pharma and Pythagoras Solar. At Qwilt, she led global financial operations and supported the company’s rapid growth.

Portrait of Nadav Yellin

Nadav Yellin

Chief Operating Officer

Nadav is a seasoned leader in cardiovascular device design with a unique track record of driving innovation from concept through clinical application. Since Valcare’s founding, he has led the company’s product development, overseeing a broad, multidisciplinary scope that spans engineering, operations, and clinical activities. His leadership integrates cross-functional teams to advance complex technologies from early development through clinical readiness.

Portrait of Madhuri Bhat

Madhuri Bhat

Chief Regulatory & Clinical Officer

Madhuri has over 25 years of experience in public affairs, public policy, due diligence, clinical, quality, and regulatory. She led several successful pivotal clinical trials and multiple registries and secured PMA, 510(K), and CE Mark regulatory approvals and clearances globally for Class II and III cardiovascular systems. Madhuri was the Chief Regulatory Officer at EBR Systems and has served as Vice-President RA/Clinical for companies in the reproductive, GI, neurological, urological, and cardiovascular such as Kyma Medical (Zoll).  Prior to that, she was the VP of RA/QC at Barrx Medical and VP of RA/Clinical at Corventis (Medtronic) and held leadership roles at Guidant and Abbott.

Board of Directors

Alessandro Piga

Executive Chairman

Alessandro serves as Executive Chairman of the Board. At TechWald, he focuses on investments in high-potential early-stage MedTech companies. With more than 40 years extensive leadership experience across Fortune 500 medical device firms – such as Johnson & Johnson, St. Jude Medical, and W. L. Gore – including roles as CEO, General Manager, and Country Manager, he brings proven board and executive insight to Valcare Medical.

Jacques Séguin MD, PhD

Director

Jacques was responsible for developing the self- expandable TAVR procedure CoreValve, a company he founded and headed which was subsequently acquired by Medtronic in 2009. After that, he was founder at ReCor Medical, a renal denervation company acquired by the Japanese company Otsuka in 2018. Jacques is currently founder, investor and board member of many innovative medtech companies.

Jeffrey Jump

Director

Jeffrey has over 45 years of medical device experience and 20 years at the board level. He founded and served as Chairman & CEO of MedAlliance, sold to Cordis for $1.2 billion. Jeffrey previously led publicly listed Biosensors International as CEO, President, Board Director while growing it to the world’s 4 th largest cardiac drug-eluting stent supplier. He chairs Casper Medical, TexRay, Transluminal/ Circlage and serves on Valcare, Compahya SA. boards.

Chris Richardson

Director

Chris has over 30 years of experience in medical devices and an extensive record of leading startups from clinical study phase through regulatory approvals and launch to acquisition. Prior, he served as President & CEO of Keystone Heart which was acquired by Venus Medtech in 2018 and also as International President & CEO of Direct Flow Medical and General Manager of Evalve (now MitraClip/Abbott).

Steve Sandweg

Director

Steve brings over 30 years of sales leadership and commercial experience in cardiovascular and structural heart technologies. His career includes progressively senior roles at Boston Scientific, Medtronic, Direct Flow Medical, Keystone Heart, and EBR Systems, where he most recently served as General Manager and Chief Commercial Officer, respectively.

Scientific Advisors

Dr. Scott Lim, MD

Professor of Medicine & Pediatrics
Director – Advanced Cardiac Valve Center, Cardiovascular Division
University of Virginia School of Medicine
Charlottesville, VA, USA

Dr. Isaac George, MD

Surgical Director, Structural Heart and Valve Center
Surgical Director, Structural Heart Disease at New York-Presbyterian Hospital
Co-Director, Mitral and Tricuspid Center Columbia University
Medical Center/New York-Presbyterian
New York, NY, USA

Dr. Paul Sorajja, MD

Professor of Medicine,
Associate Director of the Banner Heart Institute,
Director of Interventional Cardiology and Structural Heart, and Lentsch Family
Director of Structural Heart for Banner Cardiovascular service line
Banner University Medical Center
Phoenix, AZ, USA

Dr. Azeem Latib, MD

Director of Structural Heart Interventions, Montefiore Health System
NY, New York, USA

Dr. Federico DeMarco, MD, PhD

Head of the Structural Heart Program and of the Interventional, Valvular and Structural Heart Interventions Unit
Centro Cardiologico Monzino
Milan, Italy